TOT BIOPHARM International Co. Ltd. (HK:1875) has released an update.
In a sweeping victory during the adjourned annual general meeting, TOT BIOPHARM International Co. Ltd. saw all proposed resolutions passed with overwhelming majority votes. Key resolutions included the approval of audited financial statements, re-election of board members, and adoption of a new restricted share award scheme. Shareholders also granted the directors mandates to allot and buy back shares, underscoring strong investor confidence in the company’s governance.
For further insights into HK:1875 stock, check out TipRanks’ Stock Analysis page.
